205 related articles for article (PubMed ID: 12212589)
1. Treatment effects in patients with squamous cell carcinoma of the oral cavity.
Inagi K; Takahashi H; Okamoto M; Nakayama M; Makoshi T; Nagai H
Acta Otolaryngol Suppl; 2002; (547):25-9. PubMed ID: 12212589
[TBL] [Abstract][Full Text] [Related]
2. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity.
Schwartz GJ; Mehta RH; Wenig BL; Shaligram C; Portugal LG
Head Neck; 2000 Jan; 22(1):34-41. PubMed ID: 10585603
[TBL] [Abstract][Full Text] [Related]
3. Analysis of treatment results for floor-of-mouth cancer.
Sessions DG; Spector GJ; Lenox J; Parriott S; Haughey B; Chao C; Marks J; Perez C
Laryngoscope; 2000 Oct; 110(10 Pt 1):1764-72. PubMed ID: 11037841
[TBL] [Abstract][Full Text] [Related]
4. Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced-stage oral cavity cancers.
Lin CY; Wang HM; Kang CJ; Lee LY; Huang SF; Fan KH; Chen EY; Chen IH; Liao CT; Chang JT
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1011-9. PubMed ID: 20434273
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.
Noble AR; Greskovich JF; Han J; Reddy CA; Nwizu TI; Khan MF; Scharpf J; Adelstein DJ; Burkey BB; Koyfman SA
Anticancer Res; 2016 Feb; 36(2):785-92. PubMed ID: 26851040
[TBL] [Abstract][Full Text] [Related]
6. Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients.
El-Naaj IA; Leiser Y; Shveis M; Sabo E; Peled M
J Oral Maxillofac Surg; 2011 Oct; 69(10):2674-9. PubMed ID: 21571415
[TBL] [Abstract][Full Text] [Related]
7. [A study on survival rates of oral squamous cell carcinoma].
Chen GS; Chen CH
Kaohsiung J Med Sci; 1996 Jun; 12(6):317-25. PubMed ID: 8699569
[TBL] [Abstract][Full Text] [Related]
8. Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories.
Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
Cancer; 2007 Aug; 110(3):564-71. PubMed ID: 17577219
[TBL] [Abstract][Full Text] [Related]
9. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
10. The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity.
Kang CJ; Lin CY; Wang HM; Fan KH; Ng SH; Lee LY; Chen IH; Huang SF; Liao CT; Yen TC
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e223-30. PubMed ID: 21640500
[TBL] [Abstract][Full Text] [Related]
11. Stage IV oral cavity carcinoma. Is conventional radical treatment an option?
Al-Rajhi N; Saleem M; Al-Amro AS; El-Enbaby AM; El-Husseiny GA; Mahasin ZZ; Taibah KM; Al-Zahrani AM
Saudi Med J; 2002 Sep; 23(9):1095-8. PubMed ID: 12370720
[TBL] [Abstract][Full Text] [Related]
12. The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer.
Iype EM; Sebastian P; Mathew A; Balagopal PG; Varghese BT; Thomas S
Oral Oncol; 2008 Dec; 44(12):1134-8. PubMed ID: 18486527
[TBL] [Abstract][Full Text] [Related]
13. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity.
Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):137-48. PubMed ID: 9300748
[TBL] [Abstract][Full Text] [Related]
14. Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study.
Sowder JC; Cannon RB; Buchmann LO; Hunt JP; Hitchcock Y; Lloyd S; Grossmann KF; Monroe MM
Head Neck; 2017 May; 39(5):876-880. PubMed ID: 28236368
[TBL] [Abstract][Full Text] [Related]
15. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
16. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.
Brandwein-Gensler M; Teixeira MS; Lewis CM; Lee B; Rolnitzky L; Hille JJ; Genden E; Urken ML; Wang BY
Am J Surg Pathol; 2005 Feb; 29(2):167-78. PubMed ID: 15644773
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma of the buccal mucosa: one institution's experience with 119 previously untreated patients.
Diaz EM; Holsinger FC; Zuniga ER; Roberts DB; Sorensen DM
Head Neck; 2003 Apr; 25(4):267-73. PubMed ID: 12658730
[TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma of the floor of mouth: a 20-year review.
Hicks WL; Loree TR; Garcia RI; Maamoun S; Marshall D; Orner JB; Bakamjian VY; Shedd DP
Head Neck; 1997 Aug; 19(5):400-5. PubMed ID: 9243267
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome of combined modalities for buccal cancers: unilateral or bilateral neck radiation?
Lin CY; Lee LY; Huang SF; Kang CJ; Fan KH; Wang HM; Chen EY; Chen IH; Liao CT; Cheng AJ; Chang JT
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1373-81. PubMed ID: 18374224
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.
Pederson AW; Salama JK; Witt ME; Stenson KM; Blair EA; Vokes EE; Haraf DJ
Am J Clin Oncol; 2011 Aug; 34(4):356-61. PubMed ID: 21633289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
